Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.

Carminati L, Pinessi D, Borsotti P, Minoli L, Giavazzi R, D'Incalci M, Belotti D, Taraboletti G.

Carcinogenesis. 2018 Dec 13. doi: 10.1093/carcin/bgy177. [Epub ahead of print]

PMID:
30544170
2.

Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO).

Bassetti B, Carbucicchio C, Catto V, Gambini E, Rurali E, Bestetti A, Gaipa G, Belotti D, Celeste F, Parma M, Righetti S, Biava L, Arosio M, Bonomi A, Agostoni P, Scacciatella P, Achilli F, Pompilio G.

Stem Cell Res Ther. 2018 Sep 14;9(1):235. doi: 10.1186/s13287-018-0969-z.

3.

The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2).

Rusnati M, Borsotti P, Moroni E, Foglieni C, Chiodelli P, Carminati L, Pinessi D, Annis DS, Paiardi G, Bugatti A, Gori A, Longhi R, Belotti D, Mosher DF, Colombo G, Taraboletti G.

Angiogenesis. 2018 Aug 30. doi: 10.1007/s10456-018-9644-3. [Epub ahead of print]

PMID:
30168023
4.

Prognostic factors for short-term and long-term outcomes of gastric cancer surgery for elderly patients: 10 years of experience at a single tertiary care center.

de Pascale S, Belotti D, Celotti A, Minerva EM, Quagliuolo V, Rosati R, Romario UF.

Updates Surg. 2018 Jun;70(2):265-271. doi: 10.1007/s13304-018-0548-y. Epub 2018 Jun 30.

PMID:
29961192
5.

Soluble stroma-related biomarkers of pancreatic cancer.

Resovi A, Bani MR, Porcu L, Anastasia A, Minoli L, Allavena P, Cappello P, Novelli F, Scarpa A, Morandi E, Falanga A, Torri V, Taraboletti G, Belotti D, Giavazzi R.

EMBO Mol Med. 2018 Aug;10(8). pii: e8741. doi: 10.15252/emmm.201708741.

6.

Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.

Introna M, Lussana F, Algarotti A, Gotti E, Valgardsdottir R, Micò C, Grassi A, Pavoni C, Ferrari ML, Delaini F, Todisco E, Cavattoni I, Deola S, Biagi E, Balduzzi A, Rovelli A, Parma M, Napolitano S, Sgroi G, Marrocco E, Perseghin P, Belotti D, Cabiati B, Gaipa G, Golay J, Biondi A, Rambaldi A.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2070-2078. doi: 10.1016/j.bbmt.2017.07.005. Epub 2017 Jul 13.

7.

Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF.

Belotti D, Capelli C, Resovi A, Introna M, Taraboletti G.

Matrix Biol. 2016 Sep;55:106-116. doi: 10.1016/j.matbio.2016.03.003. Epub 2016 Mar 16.

PMID:
26992552
8.

Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.

Belotti D, Gaipa G, Bassetti B, Cabiati B, Spaltro G, Biagi E, Parma M, Biondi A, Cavallotti L, Gambini E, Pompilio G.

Biomed Res Int. 2015;2015:473159. doi: 10.1155/2015/473159. Epub 2015 Oct 1.

9.

Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.

Decio A, Cesca M, Bizzaro F, Porcu L, Bettolini R, Ubezio P, Taraboletti G, Belotti D, Giavazzi R.

Clin Exp Metastasis. 2015 Oct;32(7):647-58. doi: 10.1007/s10585-015-9734-1. Epub 2015 Jul 17.

PMID:
26185056
10.

Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1.

Dossi R, Frapolli R, Di Giandomenico S, Paracchini L, Bozzi F, Brich S, Castiglioni V, Borsotti P, Belotti D, Uboldi S, Sanfilippo R, Erba E, Giavazzi R, Marchini S, Pilotti S, D'Incalci M, Taraboletti G.

Int J Cancer. 2015 Feb 1;136(3):721-9. doi: 10.1002/ijc.29023. Epub 2014 Jun 19.

11.

Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.

Decio A, Taraboletti G, Patton V, Alzani R, Perego P, Fruscio R, Jürgensmeier JM, Giavazzi R, Belotti D.

Am J Pathol. 2014 Apr;184(4):1050-1061. doi: 10.1016/j.ajpath.2013.12.030. Epub 2014 Feb 6. Erratum in: Am J Pathol. 2014 Jul;184(7):2144.

PMID:
24508126
12.

Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.

Introna M, Lucchini G, Dander E, Galimberti S, Rovelli A, Balduzzi A, Longoni D, Pavan F, Masciocchi F, Algarotti A, Micò C, Grassi A, Deola S, Cavattoni I, Gaipa G, Belotti D, Perseghin P, Parma M, Pogliani E, Golay J, Pedrini O, Capelli C, Cortelazzo S, D'Amico G, Biondi A, Rambaldi A, Biagi E.

Biol Blood Marrow Transplant. 2014 Mar;20(3):375-81. doi: 10.1016/j.bbmt.2013.11.033. Epub 2013 Dec 7.

13.

Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.

Bonezzi K, Belotti D, North BJ, Ghilardi C, Borsotti P, Resovi A, Ubezio P, Riva A, Giavazzi R, Verdin E, Taraboletti G.

Neoplasia. 2012 Sep;14(9):846-54.

14.

Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models.

Oliva P, Decio A, Castiglioni V, Bassi A, Pesenti E, Cesca M, Scanziani E, Belotti D, Giavazzi R.

Br J Cancer. 2012 Jul 10;107(2):360-9. doi: 10.1038/bjc.2012.261. Epub 2012 Jun 19.

15.

Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring.

Dander E, Lucchini G, Vinci P, Introna M, Masciocchi F, Perseghin P, Balduzzi A, Bonanomi S, Longoni D, Gaipa G, Belotti D, Parma M, Algarotti A, Capelli C, Golay J, Rovelli A, Rambaldi A, Biondi A, Biagi E, D'Amico G.

Leukemia. 2012 Jul;26(7):1681-4. doi: 10.1038/leu.2011.384. Epub 2012 Jan 13. No abstract available.

PMID:
22289986
16.

[Robotic rectal resection in rectal cancer: short term results in a monocentric prospective study].

Bianchi P, Petz W, Spinoglio G, Belotti D, Bertani E, Zampino MG, Crosta C, Lazzari R, Andreoni B.

Minerva Chir. 2011 Dec;66(6):527-35. Italian.

PMID:
22233659
17.

Targeting angiogenesis with compounds from the extracellular matrix.

Belotti D, Foglieni C, Resovi A, Giavazzi R, Taraboletti G.

Int J Biochem Cell Biol. 2011 Dec;43(12):1674-85. doi: 10.1016/j.biocel.2011.08.012. Epub 2011 Aug 17. Review.

PMID:
21864705
18.

Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks.

Naldini A, Morena E, Belotti D, Carraro F, Allavena P, Giavazzi R.

Thromb Haemost. 2011 Oct;106(4):705-11. doi: 10.1160/TH11-05-0311. Epub 2011 Aug 11.

PMID:
21833453
19.

Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.

Lucchini G, Introna M, Dander E, Rovelli A, Balduzzi A, Bonanomi S, Salvadè A, Capelli C, Belotti D, Gaipa G, Perseghin P, Vinci P, Lanino E, Chiusolo P, Orofino MG, Marktel S, Golay J, Rambaldi A, Biondi A, D'Amico G, Biagi E.

Biol Blood Marrow Transplant. 2010 Sep;16(9):1293-301. doi: 10.1016/j.bbmt.2010.03.017. Epub 2010 Mar 27.

20.

GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.

Gaipa G, Tilenni M, Straino S, Burba I, Zaccagnini G, Belotti D, Biagi E, Valentini M, Perseghin P, Parma M, Campli CD, Biondi A, Capogrossi MC, Pompilio G, Pesce M.

J Cell Mol Med. 2010 Jun;14(6B):1619-34. doi: 10.1111/j.1582-4934.2009.00854.x. Epub 2009 Jul 20.

21.

The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs.

Capelli C, Salvade A, Pedrini O, Barbui V, Gotti E, Borleri G, Cabiati B, Belotti D, Perseghin P, Bellavita P, Biondi A, Biagi E, Rambaldi A, Golay J, Introna M.

Cytotherapy. 2009;11(4):403-13. doi: 10.1080/14653240902960437.

PMID:
19462317
22.

Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.

Bresin E, Gastoldi S, Daina E, Belotti D, Pogliani E, Perseghin P, Scalzulli PR, Paolini R, Marcenò R, Remuzzi G, Galbusera M.

Thromb Haemost. 2009 Feb;101(2):233-8.

PMID:
19190804
23.

Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion.

Belotti D, Calcagno C, Garofalo A, Caronia D, Riccardi E, Giavazzi R, Taraboletti G.

Mol Cancer Res. 2008 Apr;6(4):525-34. doi: 10.1158/1541-7786.MCR-07-0366.

24.

GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease.

Salvadè A, Belotti D, Donzelli E, D'Amico G, Gaipa G, Renoldi G, Carini F, Baldoni M, Pogliani E, Tredici G, Biondi A, Biagi E.

Cytotherapy. 2007;9(5):427-38.

PMID:
17786604
25.

Successful treatment with T-depleted autologous peripheral blood stem cell transplantation of refractory chronic autoimmune thrombocytopenic purpura.

Elli E, Parma M, Perseghin P, Dassi M, Terruzzi E, Belotti D, Pioltelli P, Poglian EM.

Haematologica. 2007 Jan;92(1):e7-8.

26.

Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors.

Cossy J, Belotti D, Brisson M, Skoko JJ, Wipf P, Lazo JS.

Bioorg Med Chem. 2006 Sep 15;14(18):6283-7. Epub 2006 Jun 16.

PMID:
16782352
27.

CD34+ stem cell recovery after positive selection of "overloaded" immunomagnetic columns.

Perseghin P, Gaipa G, Dassi M, Belotti D, Pogliani EM, Pioltelli P, Balduzzi A, Rovelli A, Uderzo C, Biondi A.

Stem Cells Dev. 2005 Dec;14(6):740-3.

PMID:
16433629
28.

Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds.

Perseghin P, Sciorelli G, Belotti D, Speranza T, Pogliani EM, Ferro O, Gianoli M, Porta F, Paolini G.

Transfusion. 2005 Sep;45(9):1544-6. No abstract available.

PMID:
16131392
29.

Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy.

Manenti L, Riccardi E, Marchini S, Naumova E, Floriani I, Garofalo A, Dossi R, Marrazzo E, Ribatti D, Scanziani E, Bani M, Belotti D, Broggini M, Giavazzi R.

Mol Cancer Ther. 2005 May;4(5):715-25.

30.

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.

Galbusera M, Bresin E, Noris M, Gastoldi S, Belotti D, Capoferri C, Daina E, Perseghin P, Scheiflinger F, Fakhouri F, Grünfeld JP, Pogliani E, Remuzzi G.

Blood. 2005 Aug 1;106(3):925-8. Epub 2005 Apr 12.

31.

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies.

Ruiz-Torres MP, Casiraghi F, Galbusera M, Macconi D, Gastoldi S, Todeschini M, Porrati F, Belotti D, Pogliani EM, Noris M, Remuzzi G.

Thromb Haemost. 2005 Mar;93(3):443-52.

PMID:
15735793
32.

A one-pot reformatsky/cyclopropanation sequence induced by diethylzinc.

Laroche MF, Belotti D, Cossy J.

Org Lett. 2005 Jan 20;7(2):171-3.

PMID:
15646950
33.

Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.

Kaur G, Belotti D, Burger AM, Fisher-Nielson K, Borsotti P, Riccardi E, Thillainathan J, Hollingshead M, Sausville EA, Giavazzi R.

Clin Cancer Res. 2004 Jul 15;10(14):4813-21.

34.

Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators.

Perseghin P, Mascaretti L, Speranza T, Belotti D, Baldini V, Dassi M, Riva M, Pogliani EM, Sciorelli G.

Transfusion. 2004 Jan;44(1):125-30.

PMID:
14692978
35.
36.
37.

Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.

Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G, Giavazzi R.

Cancer Res. 2003 Sep 1;63(17):5224-9.

38.

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.

Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, Buda A, Taraboletti G, Labianca R, Belotti D, Giavazzi R.

Eur J Cancer. 2003 Sep;39(13):1948-56.

PMID:
12932675
39.
40.

Synthesis of ML-3000, an Inhibitor of Cyclooxygenase and 5-Lipoxygenase.

Cossy J, Belotti D.

J Org Chem. 1997 Nov 14;62(23):7900-7901. No abstract available.

PMID:
11671883
41.

A short synthesis of argatroban. a potent selective thrombin inhibitor.

Cossy J, Belotti D.

Bioorg Med Chem Lett. 2001 Aug 6;11(15):1989-92.

PMID:
11454464
42.
43.

MMP inhibitors: experimental and clinical studies.

Belotti D, Paganoni P, Giavazzi R.

Int J Biol Markers. 1999 Oct-Dec;14(4):232-8. Review.

PMID:
10669951
44.

P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival.

Pogliani EM, Carpenedo M, Miccolis I, Belotti D, Corneo GM.

Hematology. 2000;5(5):359-67. doi: 10.1080/10245332.2000.11746531.

PMID:
27420927
45.

HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes.

Alami Y, Castronovo V, Belotti D, Flagiello D, Clausse N.

Biochem Biophys Res Commun. 1999 Apr 21;257(3):738-45.

PMID:
10208853
46.

Expression and modulation of homeobox genes from cluster B in endothelial cells.

Belotti D, Clausse N, Flagiello D, Alami Y, Daukandt M, Deroanne C, Malfoy B, Boncinelli E, Faiella A, Castronovo V.

Lab Invest. 1998 Oct;78(10):1291-9.

PMID:
9800955
47.

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

Gambacorti-Passerini C, le Coutre P, Mologni L, Fanelli M, Bertazzoli C, Marchesi E, Di Nicola M, Biondi A, Corneo GM, Belotti D, Pogliani E, Lydon NB.

Blood Cells Mol Dis. 1997 Dec;23(3):380-94.

PMID:
9446752
48.

The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.

Taraboletti G, Belotti D, Borsotti P, Vergani V, Rusnati M, Presta M, Giavazzi R.

Cell Growth Differ. 1997 Apr;8(4):471-9.

49.

TNP-470 (AGM-1470): mechanisms of action and early clinical development.

Castronovo V, Belotti D.

Eur J Cancer. 1996 Dec;32A(14):2520-7. Review. No abstract available.

PMID:
9059342
50.

The microtubule-affecting drug paclitaxel has antiangiogenic activity.

Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G.

Clin Cancer Res. 1996 Nov;2(11):1843-9.

Supplemental Content

Loading ...
Support Center